Recurrent sinusitis: Examining medical treatment options

American Journal of Rhinology

Volumn 11, Issue 2, 1997, Pages 123-132

  Kaliner, Michael A ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BECLOMETASONE; BUDESONIDE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DECONGESTIVE AGENT; DEXAMETHASONE; FLUNISOLIDE; FLUTICASONE; GLUCOCORTICOID; OXYMETAZOLINE; TRIAMCINOLONE ACETONIDE;

COMPLICATION; DIFFERENTIAL DIAGNOSIS; HUMAN; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PATIENT EDUCATION; RECURRENT DISEASE; REVIEW; SINUSITIS; SYMPTOM;

EID: 0030988313     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065897782537250     Document Type: Review

References (44)

1. McNally PA, White MV, Kaliner MA. Chronic sinusitis in an allergy office. J Allergy Clin Immunol 97:189, 1996.
2. Chow AW, Vortel JJ. Infections of the sinuses and parameningeal structures, in Gorbach SL, Bartlett JG, NR Blacklow (eds), Infectious Diseases. Philadelphia: WB Saunders Company, 1992, pp. 431-137.
3. Friday GA, Fireman P. Inflammatory disorders of the airways - sinusitis and asthma: Clinical and pathogenic relationships. Clinics in Chest Medicine 9:557-565, 1988.
4. Kaliner MA. Human nasal host defense and sinusitis (with panel discussion). J Allergy Clin Immunol 90 (part 2):424-432, 1992.
5. Knutsen AP. Mucosal and systemic immunodeficiency, In Druce HM (ed). Sinusitis. New York: Marcel Dekker, Inc., 1993.
6. Delacroix DL, Dive C, Rambaud JC, Vaerman JP. IgA subclasses in various secretions and in serum. Immunology 47:383-385, 1982.
7. Kilian M, Mestecky J, Kulhavy R, et al. IgA, proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: Comparative immuno-chemical studies. J Immunol 124:2596-2600, 1980.
8. Mulks MH, Plaut AG. IgA protease production as a characteristic distinguishing pathogenic from harmless Neisseriaceae. N Engl J Med 299:973-976, 1978.
9. Taylor HP, Dimmock NJ. Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG. J Exp Med 161:198-209, 1985.
10. Stokes CR, Soothill JF, Turner MW. Immune exclusion is a function of IgA. Nature 255:745-746, 1975.
11. Walker WA, Wu M, Isselbacher KJ, Bloch KJ. Intestinal uptake of macromolecules, III. Studies on the mechanisms by which immunization interferes with antigen uptake. J Immunol 115:854-861, 1975.
12. Meredith SD, Raphael GD, Baraniuk JN, Banks SM, Kaliner MA. The pathogenesis of rhinitis. III. The control of IgG secretion. J Allergy Clin Immunol 84:920-930, 1989.
13. Mygind N, Weeke B, Ullman S. Quantitative determination of immunoglobulins in nasal secretions. Int Arch Allergy Appl Immunol 49:99-107, 1975.
14. Igarashi Y, Skoner D, Fireman P, Doyle W, White M, Kaliner M. Phases of nasal secretions during upper respiratory viral infections. Am Rev Respir Dis 143:A757, 1991.
15. Jeney EV, Raphael GD, Meredith SD, Kaliner MA. Abnormal nasal glandular secretion in recurrent sinusitis. J Allergy Clin Immunol 86:10-18, 1990.
16. Ohashi Y, Nakai Y. Functional and morphological pathology of chronic sinusitis mucous membrane. Acta Otolaryngol Suppl (Stockholm) 397:11-48, 1983.
17. Harlin SL, Ansel DG, Lane SR, et al. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 81:867-875, 1988.
18. Druce HM, Slavin RG. Sinusitis: A critical need for further study. J Allergy Clin Immunol 88(4):675-677, 1991.
19. Minotti DA. Allergic rhinitis and sinusitis. Immunol Allergy Clin North Am 14:113-127, 1994.
20. Kaliner MA, Lemanske R. Primer on allergic and immunologic diseases - third edition: Rhinitis and asthma. JAMA 268:2807-2829, 1992.
21. Schaffer FM, Monteiro RC, Volanakis JE, Cooper MD. IgA deficiency. Immunodefic Rev 3:15-44, 1991.
22. Strober W, Krakauer R, Klaevemen HL, et al. Secretory component deficiency: A disorder of the IgA immune system. N Engl J Med 294:351-356, 1976.
23. Preud'Homme JL, Hanson LA. IgG subclass deficiency. Immunodefic Rev 2:129-149, 1990.
24. Karlsson G, Brandtzaeg P, Hansson G, et al. Humoral immunity in nasal mucosa of patients with common variable immunodeficiency. J Clin Immunol 7:29-36, 1987.
25. Shapiro ED, Milmoe GJ, Wald ER, et al. Bacteriology of the maxillary sinuses in patients with cystic fibrosis. J Infect Dis 146:589, 1982.
26. Zurlo JJ, Feuerstein IM, Lebovics R, Lane HC. Sinusitis in HIV-1 infection. JAMA. 93:157-162, 1992.
27. Melen I, Andreasson L. Short and long-term treatment results in chronic maxillary sinusitis. Acta Otolaryngol 102:282, 1986.
28. Atrovent. "In brief." F-D-C Reports: "The Pink Sheet." February 5, 1996; p. 34.
29. Zeiger RS. Prospects for ancillary treatment of sinusitis in the 1990s. J Allergy Clin Immunol 90:478-495, 1992.
30. Qvarnberg Y, Kantola O, Salo J, et al. Influence of topical steroid treatment on maxillary sinusitis. Rhinology 30:103-112. 1992.
31. Mabry RL. Step III: Corticosteroids in the management of upper respiratory allergy: The emerging role of steroid nasal sprays (with panel discussion). Otolaryngol Head Neck Surg 107:855-860, 1992.
32. Mabry RL. Corticosteroids in otolaryngology: Nasal aerosols. Otolaryngol Head Neck Surg 100:635-636, 1989.
33. Mabry RL. Corticosteroids in rhinology. Otolaryngol Head Neck Surg 108:768-770, 1993.
34. Sykes DA, Wilson R, Chan KL, et al. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis: A controlled study. Lancet 359-360, August 16, 1986.
35. Corey JP, Bumsted R, Panje W, Namon A. Orbital complications in functional endoscopic sinus surgery. Otolaryngol Head Neck Surg 109:814-820, 1993.
36. Physicians' Desk Reference, 48th ed. 475-477, 1439-1441, 1856-1859, 2365-2366, 1994.
37. The Drug Committee on the Research Council of the American Academy of Allergy. A double-blind labeled study of dexamethasone nasal aerosol (Turbinaire) vs. placebo in the treatment of nasal polyposis. J Allergy 41:10-13, 1968.
38. Nsouli TM, Nsouli SM, Scanlon RT, Bellanti. Comparison of intranasal dexamethasone (DM) and placebo (P) for nasal polyposis. Poster presentation at the American College of Allergy and Immunology Annual Meeting, San Francisco, CA, November 4, 1994.
39. van As A, Bronsky EA, Dockhorn RJ, et al. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone dipropionate. J Allergy Clin Immunol 91:1146-1154, 1993.
40. Meltzer EO, Busse WW, Druce HM, et al. Assessment of flunisolide nasal spray vs. placebo as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 92:812-823, 1993.
41. Kaliner MA, McNally PA, White MV. Treatment of chronic sinusitis in an allergy office. J Allergy Clin Immunol 97:190, 1996.
42. Rachelfsky G, Adelglass J, Corren J, et al. Evaluation of safety and efficacy of Dexacort™ Turbinaire (DEX) nasal spray in patients with perennial allergic rhinitis. J Allergy Clin Immunol 97:434, 1996.
43. Goodman GM, Slavin RG. Chronic sinus disease: medical management in adults. Immunol Allergy Clin North Am 141:69-87, 1994.
44. Intranasal Steroids. In Drug Facts and Comparisons. St Louis: Facts and Comparisons, Inc.; 1996 (updates): 187, 187a, 187b.